Risk factors for the development of glaucomatous visual field loss in ocular hypertension.
about
Clinical effectiveness of brinzolamide 1%-brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertensionBlindness and Glaucoma: A Multicenter Data Review from 7 Academic Eye ClinicsIntraocular pressure fluctuations in professional brass and woodwind musicians during common playing conditions.The Finnish evidence-based guideline for open-angle glaucoma.Functional and structural measurements in a multifactorial glaucoma risk model.Glaucoma and vasospasm.Laser scanning tomography of the optic nerve head in ocular hypertension and glaucomaDominant inheritance of retinal ganglion cell resistance to optic nerve crush in mice.Rgcs1, a dominant QTL that affects retinal ganglion cell death after optic nerve crush in mice.Bioinformatic and statistical analysis of the optic nerve head in a primate model of ocular hypertension.The effect of acute intraocular pressure elevation on peripapillary retinal thickness, retinal nerve fiber layer thickness, and retardance.Differential response of C57BL/6J mouse and DBA/2J mouse to optic nerve crushVascular risk factors for open angle glaucoma in african eyes.Genetic heterogeneity of primary open angle glaucoma and ocular hypertension: linkage to GLC1A associated with an increased risk of severe glaucomatous optic neuropathy.Nitric-oxide synthase and neurodegeneration/neuroprotection.Interocular symmetry in peripapillary retinal nerve fiber layer thickness measured with the Cirrus HD-OCT in healthy eyesDeterminants of normal retinal nerve fiber layer thickness measured by Stratus OCT.Choroidal hemodynamic in myopic patients with and without primary open-angle glaucoma.Does optic nerve head size variation affect circumpapillary retinal nerve fiber layer thickness measurement by optical coherence tomography?Retinal nerve fiber layer thickness in glaucomatous Nepalese eyes and its relation with visual field sensitivity.The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: an application of latent class analysisThe accuracy and clinical application of predictive models for primary open-angle glaucoma in ocular hypertensive individuals.Why Do People (Still) Go Blind from Glaucoma?Comparison of newly diagnosed ocular hypertension and open-angle glaucoma: ocular variables, risk factors, and disease severity.The bugeye mutant zebrafish exhibits visual deficits that arise with the onset of an enlarged eye phenotype.Retinal nerve fibre layer and visual function loss in glaucoma: the tipping pointCorrelation of retinal nerve fiber layer thickness and visual fields in glaucoma: a broken stick model.Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma.Effects of age and diabetes on scleral stiffness.Optic disk size and glaucomaThe epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003.Detecting glaucoma with RADAAR: the Bridlington Eye Assessment ProjectSurgical lowering of elevated intraocular pressure in monkeys prevents progression of glaucomatous disease.Ultrahigh-resolution optical coherence tomography in glaucomaOptical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma.Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up.Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertensionInterocular Symmetry of Macular Ganglion Cell Complex Thickness in Young Chinese Subjects.Clinical characteristics of newly diagnosed primary, pigmentary and pseudoexfoliative open-angle glaucoma in the Collaborative Initial Glaucoma Treatment Study.Primary Open-Angle Glaucoma in Individuals of African Descent: A Review of Risk Factors
P2860
Q26773219-73CB0DD5-7885-46C5-8387-AA09AC52C7C0Q30000044-09997B8F-CAC7-48F0-A5D4-9068D45AF47AQ30552848-B5A06C89-D915-4D01-93A4-907B93BE9C99Q31134829-131F40FD-EF83-458F-AFCE-10718C467BC0Q31890752-12C01F7C-80ED-44A0-ADA5-76D2B7921B5CQ31966621-0CBD3FA3-FAEF-49EE-B440-1EB628419DEDQ32107152-E18ED507-90C9-4401-B571-DE2D713023B3Q33276940-BEAB48FF-EF54-451C-816C-B7C9F14613ECQ33356801-9FCA28E8-15EE-48E6-9AFA-3077523DB3E4Q33372453-7D29C95F-174E-44BF-943C-C06D92E3D296Q33440167-DBD27151-3F81-4BEE-9B67-A37D50ACD73BQ33488710-5C362ADD-71E8-49B4-BA71-5110D739B9C1Q33619441-3CD70E2C-B55A-453E-A4DC-CC3637557AF3Q33679090-3B5676FA-A672-4350-A554-4963A90BCAB9Q33712796-567CF8E0-CC02-4192-B3ED-B1098F33D691Q33760281-15A23A74-EAE3-4159-B6A2-98B30901FA4BQ34044571-8FFC7EE5-E1F3-4AB0-8281-FE2E6DDBF9A5Q34212758-03BADC32-A68C-446E-9F8A-A32814DE5ECEQ34320352-65B7C901-E0E9-4DDB-A5D7-3EE9E22A4BA2Q34424665-892B8AD1-3244-42EA-BD8F-2ACA4326D909Q34433542-CA3442A7-0D3A-48AE-B0CE-A449F3B877F4Q35052597-A816D5E9-CD93-44DD-A6D6-0B77EE7C7A92Q35160642-694350CA-B121-4CEA-B808-208B58C249F9Q35173258-8915925B-9AE4-44FA-93CA-E8D731690D3CQ35221061-4F916AA5-EFD9-4919-A741-A988CB278D73Q35354071-1879809D-36A2-4209-AADD-FF8D88EE11FEQ35580019-BD2915F8-ACA2-47ED-A45B-DEA7861ED609Q35681331-7A567D48-B6B7-4C8A-A962-D44EDDE2F659Q35717308-A0292085-249B-4C66-A0D9-5E9B183E74BFQ35748411-08B82543-8675-4FBD-8737-2C5AA59AF1BFQ35761955-1A2D2DEE-8FFF-443F-9A72-D7B43DD89F1EQ35769418-698D7AAB-0541-4A64-BA22-D6C77C0D3B6FQ35777463-63F78B4E-3743-48E3-9E16-1ACB4B140802Q35920307-C2DBFE9C-BA24-4054-9ECC-E6A02160BB20Q35928721-DAE27AB2-52AD-46BF-8319-AA104431E6C5Q36016475-4CFE9AE5-7726-4D76-B64A-B71D07D8AEB5Q36016893-5281E974-960E-4346-B708-B8ACB753ADB5Q36084545-07AEA8A4-4746-4F79-B216-53952431828BQ36344867-FBD5CB17-81EE-4288-8D09-3D1CC11E1D76Q36351687-5EBD3143-BD4C-46D5-A922-CECA212AE89C
P2860
Risk factors for the development of glaucomatous visual field loss in ocular hypertension.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Risk factors for the developme ...... d loss in ocular hypertension.
@en
type
label
Risk factors for the developme ...... d loss in ocular hypertension.
@en
prefLabel
Risk factors for the developme ...... d loss in ocular hypertension.
@en
P2093
P1433
P1476
Risk factors for the developme ...... d loss in ocular hypertension.
@en
P2093
P304
P356
10.1001/ARCHOPHT.1994.01090170088028
P407
P577
1994-05-01T00:00:00Z